vs
Side-by-side financial comparison of AMREP CORP. (AXR) and Pulmonx Corp (LUNG). Click either name above to swap in a different company.
Pulmonx Corp is the larger business by last-quarter revenue ($20.6M vs $14.6M, roughly 1.4× AMREP CORP.). AMREP CORP. runs the higher net margin — 21.6% vs -66.3%, a 87.9% gap on every dollar of revenue. On growth, AMREP CORP. posted the faster year-over-year revenue change (93.8% vs -8.7%). Over the past eight quarters, Pulmonx Corp's revenue compounded faster (-0.5% CAGR vs -13.6%).
AMREP Corporation is a real estate and media services company based in Princeton, New Jersey, in the United States. It was founded in 1961 as The American Realty and Petroleum Corporation.
Pulmonx Corp is a global medical tech firm focused on interventional pulmonology solutions. It develops minimally invasive endobronchial valves to treat severe COPD and emphysema, with products sold across North America, Europe, and Asia-Pacific for patients with advanced lung conditions.
AXR vs LUNG — Head-to-Head
Income Statement — Q3 FY2026 vs Q1 FY2026
| Metric | ||
|---|---|---|
| Revenue | $14.6M | $20.6M |
| Net Profit | $3.1M | $-13.7M |
| Gross Margin | — | 77.9% |
| Operating Margin | 20.6% | -40.9% |
| Net Margin | 21.6% | -66.3% |
| Revenue YoY | 93.8% | -8.7% |
| Net Profit YoY | 338.9% | 5.5% |
| EPS (diluted) | $0.58 | $-0.33 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $14.6M | $20.6M | ||
| Q4 25 | $9.4M | $22.6M | ||
| Q3 25 | $17.9M | $21.5M | ||
| Q2 25 | $11.2M | $23.9M | ||
| Q1 25 | $7.5M | $22.5M | ||
| Q4 24 | $11.9M | $23.8M | ||
| Q3 24 | $19.1M | $20.4M | ||
| Q2 24 | $19.5M | $20.8M |
| Q1 26 | $3.1M | $-13.7M | ||
| Q4 25 | $1.2M | $-10.4M | ||
| Q3 25 | $4.7M | $-14.0M | ||
| Q2 25 | $3.9M | $-15.2M | ||
| Q1 25 | $717.0K | $-14.4M | ||
| Q4 24 | $4.0M | $-13.2M | ||
| Q3 24 | $4.1M | $-14.1M | ||
| Q2 24 | $4.1M | $-15.3M |
| Q1 26 | — | 77.9% | ||
| Q4 25 | — | 77.6% | ||
| Q3 25 | — | 74.7% | ||
| Q2 25 | — | 72.1% | ||
| Q1 25 | — | 72.5% | ||
| Q4 24 | — | 74.0% | ||
| Q3 24 | — | 73.7% | ||
| Q2 24 | — | 73.7% |
| Q1 26 | 20.6% | -40.9% | ||
| Q4 25 | 11.9% | -43.8% | ||
| Q3 25 | 34.4% | -66.9% | ||
| Q2 25 | 31.7% | -62.0% | ||
| Q1 25 | 5.7% | -64.6% | ||
| Q4 24 | 26.4% | -56.5% | ||
| Q3 24 | 26.1% | -69.3% | ||
| Q2 24 | 23.9% | -75.2% |
| Q1 26 | 21.6% | -66.3% | ||
| Q4 25 | 12.8% | -46.1% | ||
| Q3 25 | 26.3% | -64.9% | ||
| Q2 25 | 34.8% | -63.6% | ||
| Q1 25 | 9.5% | -64.1% | ||
| Q4 24 | 33.9% | -55.4% | ||
| Q3 24 | 21.3% | -69.4% | ||
| Q2 24 | 21.2% | -73.7% |
| Q1 26 | $0.58 | $-0.33 | ||
| Q4 25 | $0.22 | $-0.25 | ||
| Q3 25 | $0.87 | $-0.34 | ||
| Q2 25 | $0.73 | $-0.38 | ||
| Q1 25 | $0.13 | $-0.36 | ||
| Q4 24 | $0.75 | $-0.33 | ||
| Q3 24 | $0.76 | $-0.36 | ||
| Q2 24 | $0.77 | $-0.39 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $50.0M | $61.6M |
| Total DebtLower is stronger | $21.0K | $37.3M |
| Stockholders' EquityBook value | $139.4M | $45.8M |
| Total Assets | $143.9M | $120.0M |
| Debt / EquityLower = less leverage | 0.00× | 0.82× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $50.0M | $61.6M | ||
| Q4 25 | $44.6M | $69.8M | ||
| Q3 25 | $48.9M | $76.5M | ||
| Q2 25 | $39.5M | $75.5M | ||
| Q1 25 | $36.9M | $74.6M | ||
| Q4 24 | $40.1M | $70.9M | ||
| Q3 24 | $40.4M | $63.3M | ||
| Q2 24 | $29.7M | $63.5M |
| Q1 26 | $21.0K | $37.3M | ||
| Q4 25 | $23.0K | $37.1M | ||
| Q3 25 | $25.0K | $37.1M | ||
| Q2 25 | $26.0K | $37.1M | ||
| Q1 25 | $29.0K | $37.2M | ||
| Q4 24 | $32.0K | $37.2M | ||
| Q3 24 | $34.0K | $37.2M | ||
| Q2 24 | $35.0K | $37.2M |
| Q1 26 | $139.4M | $45.8M | ||
| Q4 25 | $136.0M | $54.1M | ||
| Q3 25 | $134.7M | $60.0M | ||
| Q2 25 | $130.0M | $69.1M | ||
| Q1 25 | $126.0M | $77.7M | ||
| Q4 24 | $125.1M | $85.8M | ||
| Q3 24 | $122.2M | $93.9M | ||
| Q2 24 | $118.0M | $101.2M |
| Q1 26 | $143.9M | $120.0M | ||
| Q4 25 | $140.1M | $129.3M | ||
| Q3 25 | $140.7M | $138.3M | ||
| Q2 25 | $133.8M | $147.2M | ||
| Q1 25 | $128.9M | $150.7M | ||
| Q4 24 | $129.1M | $162.8M | ||
| Q3 24 | $127.0M | $167.4M | ||
| Q2 24 | $122.8M | $172.6M |
| Q1 26 | 0.00× | 0.82× | ||
| Q4 25 | 0.00× | 0.69× | ||
| Q3 25 | 0.00× | 0.62× | ||
| Q2 25 | 0.00× | 0.54× | ||
| Q1 25 | 0.00× | 0.48× | ||
| Q4 24 | 0.00× | 0.43× | ||
| Q3 24 | 0.00× | 0.40× | ||
| Q2 24 | 0.00× | 0.37× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $5.4M | — |
| Free Cash FlowOCF − Capex | $5.4M | — |
| FCF MarginFCF / Revenue | 37.0% | — |
| Capex IntensityCapex / Revenue | 0.1% | — |
| Cash ConversionOCF / Net Profit | 1.72× | — |
| TTM Free Cash FlowTrailing 4 quarters | $20.2M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $5.4M | — | ||
| Q4 25 | $-4.3M | $-7.1M | ||
| Q3 25 | $9.5M | $-8.2M | ||
| Q2 25 | $10.2M | $-3.9M | ||
| Q1 25 | $-3.2M | $-13.2M | ||
| Q4 24 | $-182.0K | $-6.7M | ||
| Q3 24 | $10.7M | $-7.2M | ||
| Q2 24 | $10.7M | $-5.8M |
| Q1 26 | $5.4M | — | ||
| Q4 25 | $-4.3M | $-7.1M | ||
| Q3 25 | $9.5M | $-8.3M | ||
| Q2 25 | $9.7M | $-4.0M | ||
| Q1 25 | $-3.3M | $-13.5M | ||
| Q4 24 | $-268.0K | $-6.8M | ||
| Q3 24 | $10.7M | $-7.7M | ||
| Q2 24 | $10.3M | $-6.2M |
| Q1 26 | 37.0% | — | ||
| Q4 25 | -45.9% | -31.4% | ||
| Q3 25 | 53.2% | -38.4% | ||
| Q2 25 | 86.4% | -16.6% | ||
| Q1 25 | -43.4% | -60.0% | ||
| Q4 24 | -2.3% | -28.8% | ||
| Q3 24 | 55.8% | -37.6% | ||
| Q2 24 | 52.5% | -30.0% |
| Q1 26 | 0.1% | — | ||
| Q4 25 | 0.6% | 0.1% | ||
| Q3 25 | 0.1% | 0.4% | ||
| Q2 25 | 5.2% | 0.2% | ||
| Q1 25 | 0.3% | 1.3% | ||
| Q4 24 | 0.7% | 0.5% | ||
| Q3 24 | 0.2% | 2.0% | ||
| Q2 24 | 2.3% | 2.3% |
| Q1 26 | 1.72× | — | ||
| Q4 25 | -3.54× | — | ||
| Q3 25 | 2.03× | — | ||
| Q2 25 | 2.63× | — | ||
| Q1 25 | -4.51× | — | ||
| Q4 24 | -0.05× | — | ||
| Q3 24 | 2.63× | — | ||
| Q2 24 | 2.59× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.